Who’s To Say?
The coverage of the announced negotiation by Sanofi to divest its European generics business triggered this cranky post. I don’t quite understand why so many journalists/analysts negatively criticize management when…
The coverage of the announced negotiation by Sanofi to divest its European generics business triggered this cranky post. I don’t quite understand why so many journalists/analysts negatively criticize management when…